SELPERCATINIB, SELPERCATINIB
LOXO-RET-17001
Phase 2 small_molecule active
Quick answer
SELPERCATINIB, SELPERCATINIB for Male or female patients age 12 years or older with a locally advanced or metastatic solid tumor with evidence of a RET gene alteration in tumor and/or blood. is a Phase 2 program (small_molecule) at Ology Bioservices Ireland LTD with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Ology Bioservices Ireland LTD
- Indication
- Male or female patients age 12 years or older with a locally advanced or metastatic solid tumor with evidence of a RET gene alteration in tumor and/or blood.
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active